PDCD1 and myasthenia gravis: PD-1 expresses on activated B cells as well as activated T cells [33,36,37], which indicates that there is a potential risk of triggering B cell–mediated autoimmune disease such as MG by the blockade of the interaction between PD-1 and PD-L1.